New shot aims to tame dangerous fat levels in blood

NCT ID NCT06471543

First seen Jan 08, 2026 · Last updated May 14, 2026 · Updated 22 times

Summary

This study tests a new medicine called RN0361 in healthy adults and people with very high triglycerides (a type of fat in the blood). The goal is to see if a single dose is safe and can lower fat levels. About 108 participants will receive either the drug or a placebo. The study is in early phases (1 and 2) and is not currently recruiting.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Altona Clinical Research

    Altona N., Victoria, 3025, Australia

  • Axis Clinicals USA

    Dilworth, Minnesota, 56529, United States

  • Nucleus Network Melbourne

    Melbourne, Victoria, 3004, Australia

  • Ogden Clinic, Mountain View / Avacare

    Pleasant View, Utah, 84404, United States

  • Synergy Groups Medical

    Houston, Texas, 77061, United States

  • TBC Research LLC,

    Tamarac, Florida, 33321, United States

  • Tranquil

    Webster, Texas, 77598, United States

  • University of the Sunshine Coast Clinical Trials

    Morayfield, Queensland, Australia

  • University of the Sunshine Coast Clinical Trials, Sippy Downs

    Sippy Downs, Queensland, 4556, Australia

  • Versailles Family Medicine / Avacare

    Versailles, Kentucky, 40383, United States

Conditions

Explore the condition pages connected to this study.